CTOs on the Move


 
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nymox.com
  • Heights Plaza 777 Terrace Avenue
    Hasbrouck Heights, NJ USA 07604
  • Phone: 800.936.9669

Executives

Name Title Contact Details

Funding

Nymox raised $16.3M on 04/12/2018

Similar Companies

Navilyst Medical

Navilyst Medical is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

War Memorial Hospital

War Memorial Hospital is a Sault Sainte Marie, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GEM Health Care Services

GEM Health Care Services Inc. is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AFYA Inc

AFYA Inc is a Laurel, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mercyhealth Wisconsin and Illinois

Mercyhealth is a non-profit health care system based in Rockford, Illinois.